China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.090
+0.010 (0.48%)
At close: Apr 28, 2026, 4:00 PM EDT
2.060
-0.030 (-1.42%)
After-hours: Apr 28, 2026, 5:31 PM EDT
China SXT Pharmaceuticals Employees
China SXT Pharmaceuticals had 75 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
75
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$20,506
Profits / Employee
-$118,265
Market Cap
6.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 8 |
| Gelteq | 8 |
| PRF Technologies | 7 |
SXTC News
- 5 weeks ago - China SXT Pharmaceuticals, Inc. Announces Share Re-classification - GlobeNewsWire
- 3 months ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewsWire
- 3 months ago - Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - GlobeNewsWire
- 3 months ago - China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewsWire